Cambridge Cancer Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Cambridge Cancer Genomics's estimated annual revenue is currently $6.7M per year.
- Cambridge Cancer Genomics's estimated revenue per employee is $155,000
Employee Data
- Cambridge Cancer Genomics has 43 Employees.
Cambridge Cancer Genomics's People
| Name | Title | Email/Phone |
|---|
Cambridge Cancer Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19670M | 176108 | N/A | N/A | $30.3B |
#2 | $2880.3M | 10185 | N/A | N/A | N/A |
#3 | $28.9M | 107 | N/A | N/A | N/A |
#4 | $26.6M | 173 | N/A | N/A | N/A |
#5 | $69.3M | 390 | -36% | $97.8M | N/A |
#6 | $0.3M | 4 | N/A | N/A | N/A |
#7 | $1.6M | 10 | N/A | N/A | N/A |
#8 | $4.2M | 22 | N/A | N/A | N/A |
#9 | N/A | 7 | N/A | N/A | N/A |
#10 | $126.7M | 699 | -3% | N/A | N/A |
#11 | $435.8M | 1153 | N/A | N/A | N/A |
#12 | $0.8M | 6 | N/A | N/A | N/A |
#13 | $149.8M | 738 | 24% | N/A | N/A |
#14 | $72.1M | 298 | N/A | N/A | N/A |
#15 | $0.1M | 4 | 0% | $25.3M | N/A |
#16 | $31.6M | 210 | -5% | $195.7M | N/A |
#17 | $43.7M | 174 | N/A | N/A | N/A |
#18 | $20.4M | 120 | -14% | N/A | N/A |
#19 | $0.5M | 14 | 8% | $7.7M | N/A |
#20 | $1.5M | 22 | 5% | $5.8M | N/A |
What Is Cambridge Cancer Genomics?
N/A
Total Funding
43
Number of Employees
$6.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cambridge Cancer Genomics News
Scientists and clinicians from the Cambridge University Hospitals NHS Trust and the University of Cambridge supported by Cancer Research...
... genome sequencing data reveals new clues to causes of cancer ... of Cambridge, analysed the complete genetic make-up or whole-genome...
For years, researchers have been trawling through genomic data in search ... a computational biologist at the University of Cambridge, UK,...
Cambridge Cancer Genomics has developed blood tests to inform and support targeted cancer therapies. The goal is to reduce the time it takes to determine whether chemotherapy is working from the current timeframe of six months. Reducing that timeframe could mean more time to modify treatment and ...
John Cassidy’s family has been at the forefront of cancer research for three generations now. The Cambridge-educated co-founder and chief executive officer of cancer diagnostics company Cambridge Cancer Genomics was just following in his father’s and grandfather’s footsteps when he took up rese ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.5M | 43 | N/A | N/A |
#2 | $8.4M | 43 | N/A | N/A |
#3 | $4.8M | 43 | N/A | N/A |
#4 | $5M | 43 | N/A | N/A |
#5 | $5M | 43 | N/A | N/A |